# US 2021/0275294 A1 · Lens for use in a human or animal body, and production methods thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0275294 A1
- Document ID: US20210275294A1
- Status: Published application
- Kind: A1
- Application number: 17/269,179
- Filed: 2019-08-16
- Published: 2021-09-09
- Earliest claimed: 2018-08-17
- Assignees: Agency for Science, Technology and Research
- Applicants: Agency for Science, Technology and Research
- Inventors: Shuyan ZHANG; Malini OLIVO; Renzhe BI
- Web page: https://patentgrep.com/patent/US20210275294A1

## CPC

- A61F 2/1637: {Correcting aberrations caused by inhomogeneities; correcting intrinsic aberrations, e.g. of the cornea, of the surface of the natural lens, aspheric, cylindrical, toric lenses}
- A61B 1/00165: {with light-conductive means, e.g. fibre optics (A61B1/07 takes precedence)}
- A61B 1/00174: {characterised by the viewing angles}
- A61B 1/00188: {with focusing or zooming features}
- G02B 1/04: made of organic materials, e.g. plastics (G02B1/08 takes precedence)
- G02B 1/041: {Lenses}
- G02C 7/022: {Ophthalmic lenses having special refractive features achieved by special materials or material structures (G02C7/049 takes precedence)}
- A61F 2210/00: Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F 2230/0002: Two-dimensional shapes, e.g. cross-sections
- G02C 7/049: {Contact lenses having special fitting or structural features achieved by special materials or material structures}
- G02C 2202/24: Myopia progression prevention
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- G02B: OPTICAL ELEMENTS, SYSTEMS OR APPARATUS
- G02C: SPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES (trial frames for testing the eyes A61B3/04; goggles or eyeshields not having the same features as spectacles A61F9/00)

## Abstract

There is provided a lens for use in a human or animal body, the lens comprising a metasurface configured to modulate incident light, wherein the metasurface is composed of at least one light transmissive biomaterial. Also provided is a method of making the lens.

## Claims

### Claim 1

A lens for use in a human or animal body, the lens comprising a metasurface configured to modulate incident light, wherein the metasurface is composed of at least one light transmissive biomaterial.

### Claim 2 (depends on 1)

The lens of claim 1, wherein the lens is substantially devoid of materials that elicit an adverse physiological response.

### Claim 3 (depends on 1)

The lens of claim 1, wherein the light transmissive biomaterial has a refractive index that is no less than about 1.33.

### Claim 4 (depends on 1)

The lens of claim 1, wherein the light transmissive biomaterial is selected from the group consisting of a hydrogel, a gelatin, a silk fibroin, a polyester, a polysiloxane, a polyacrylate, an acrylate and derivatives thereof.

### Claim 5 (depends on 4)

The lens of claim 4, wherein the polyester comprises one or more monomers selected from the group consisting of glycolic acid, glycolide, D, L-lactide, D-lactide, L-lactide, D, L-lactic acid, D-lactic acid, L-lactic acid, ε-caprolactone, trimethylene carbonate, dioxanone and p-dioxanone, optionally wherein the polyester is selected from the group consisting of poly(lactic-co-glycolic acid), polyglycolide, poly(glycolic acid), poly(ε-caprolactone), poly(DL-lactide-co-ε-caprolactone), poly(DL-lactide), poly(L-lactide), polylactide, poly(lactic acid), poly(lactide-co-glycolide), poly(trimethylene carbonate), polydioxanone and poly-p-dioxanone.

### Claim 6

(canceled)

### Claim 7 (depends on 4)

The lens of claim 4, wherein the polysiloxane is selected from the group consisting of polydimethylsiloxane and polydimethyldiphenylsiloxane; the polyacrylate is selected from the group consisting of poly(ethyl methacrylate) and poly(ethyl acrylate); and the acrylate is selected from hydroxyethylmethacrylate (HEMA) and 2-phenylethyl methacrylate.

### Claim 8 (depends on 1)

The lens of claim 1, wherein the metasurface comprises patterned nanostructures disposed on a substrate.

### Claim 9 (depends on 8)

The lens of claim 8, wherein the patterned nanostructures and the substrate form a single monolithic piece of material.

### Claim 10 (depends on 8)

The lens of claim 8, wherein the nanostructures comprise nanopillars.

### Claim 11 (depends on 1)

The lens of claim 1, wherein the metasurface has a hyperboloidal phase profile φ(r,f,λ) that is defined by the formula:
φ
⁡
(
r
,
f
,
λ
)
=
±
2
⁢
π
λ
⁢
(
r
2
+
f
2
-
f
)
where λ is the wavelength, r is the radial position, f is the focal length, and the positive or negative sign is applied for diverging or converging lenses, respectively.

### Claim 12 (depends on 1)

The lens of claim 1, wherein the metasurface has a phase profile φ(total) that is defined by the formulae:
φ
total
=
φ
defl
+
φ
focus
φ
defl
⁡
(
x
,
λ
)
=
2
⁢

λ
×
(
x
)
×
sin
⁢
θ
defl
φ
focus
⁡
(
r
,
f
,
λ
)
=
-
2
⁢

λ
×
(
r
2
+
f
2
-
f
)
where θdef1 is the angle of incident light deflection in the x direction, r is the radial position, f is the focal length and λ is the wavelength of incident light.

### Claim 13 (depends on 1)

The lens of claim 1, wherein the lens has a total thickness of from 1 micron to 1000 microns.

### Claim 14 (depends on 1)

The lens of claim 1, wherein the lens is configured to change its light modulating properties in response to changes in one or more of: chemical environment, biomolecular interactions, intensity of light, electrical and/or magnetic signals, temperature, tensile stresses, or compressive stresses.

### Claim 15 (depends on 1)

The lens of claim 1, wherein the lens is one of an intraocular lens, an endoscopic lens or an implantable deep tissue imaging enhancement lens.

### Claim 16 (depends on 15)

The lens of claim 15, wherein the lens is an intraocular lens that is adapted to be coupled to haptics and/or ciliary muscles.

### Claim 17 (depends on 15)

The lens of claim 15, wherein the lens is an endoscopic lens that is adapted to be integrated directly onto an optical fiber without an intermediate medium such as a prism for redirecting incident light thereto.

### Claim 18 (depends on 15)

The lens of claim 15, wherein the lens is an implantable lens which is part of a hybrid partially-in vivo and partially-ex vivo deep-tissue optical imaging system comprising an in vivo metasurface lens and an ex vivo microscope system with a spatial light modulator for adaptive optics.

### Claim 19

A method of making a lens for use in a human or animal body, the method comprising:
patterning nanostructures on a surface of a substrate to form a metasurface configured to modulate incident light,
wherein the nanostructures are composed of a light transmissive biomaterial.

### Claim 20 (depends on 19)

The method of claim 19, wherein the step of patterning nanostructures on a surface comprises configuring the nanostructure patterns such that the formed metasurface has a hyperboloidal phase profile φ(r,f,λ) or a phase profile φ(total) that is defined respectively by the following formulae:
φ
⁡
(
r
,
f
,
λ
)
=
±
2
⁢
π
λ
⁢
(
r
2
+
f
2
-
f
)
where λ is the wavelength, r is the radial position, f is the focal length, and the positive or negative sign is applied for diverging or converging lenses, respectively; or
φ
total
=
φ
defl
+
φ
focus
φ
defl
⁡
(
x
,
λ
)
=
2
⁢

λ
×
(
x
)
×
sin
⁢
θ
defl
φ
focus
⁡
(
r
,
f
,
λ
)
=
-
2
⁢

λ
×
(
r
2
+
f
2
-
f
)
where θdef1 is the angle of incident light deflection in the x direction, r is the radial position, f is the focal length and λ is the wavelength of incident light.

### Claim 21 (depends on 19)

The method of claim 19, wherein the method is performed under sterile conditions and/or further comprises a step of sterilizing the lens.
